Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
MRNA | Moderna, Inc. | Stephen Hoge | President | Aug 12, 2024 | Sale | $84.10 | 254 | 21,363 | 1,442,357 | Aug 13, 2024, 04:33 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Jul 31, 2024 | Sale | $119.96 | 15,000 | 1,799,443 | 2,234,416 | Aug 02, 2024, 07:00 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Jul 24, 2024 | Sale | $117.80 | 15,000 | 1,766,972 | 2,251,347 | Jul 26, 2024, 07:00 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Jul 17, 2024 | Sale | $122.84 | 15,000 | 1,842,651 | 2,266,414 | Jul 19, 2024, 07:00 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | Jul 15, 2024 | Sale | $121.12 | 15,000 | 1,816,800 | 1,442,089 | Jul 16, 2024, 04:08 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Jul 10, 2024 | Sale | $117.08 | 15,000 | 1,756,177 | 2,277,894 | Jul 12, 2024, 07:00 PM | |
MRNA | Moderna, Inc. | James M. Mock | Chief Financial Officer | Jul 05, 2024 | Option/RSU Exercise | - | 1,452 | - | 7,958 | Jul 09, 2024, 04:34 PM | |
MRNA | Moderna, Inc. | James M. Mock | Chief Financial Officer | Jul 08, 2024 | Sale | $118.24 | 689 | 81,465 | 7,269 | Jul 09, 2024, 04:34 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Jun 26, 2024 | Sale | $127.22 | 15,000 | 1,908,293 | 2,296,555 | Jun 28, 2024, 07:00 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Jun 18, 2024 | Sale | $133.57 | 15,000 | 2,003,561 | 2,312,315 | Jun 21, 2024, 07:00 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | Jun 17, 2024 | Sale | $138.16 | 15,000 | 2,072,400 | 1,457,089 | Jun 18, 2024, 04:05 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Jun 12, 2024 | Sale | $147.20 | 15,000 | 2,208,071 | 2,328,315 | Jun 14, 2024, 07:00 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Jun 11, 2024 | Sale | $148.34 | 170,069 | 25,227,403 | 7,937,145 | Jun 11, 2024, 07:01 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Jun 11, 2024 | Sale | $148.34 | 32,763 | 4,859,936 | 1,529,789 | Jun 11, 2024, 07:01 PM | |
MRNA | Moderna, Inc. | Shannon Thyme Klinger | Chief Legal Officer | Jun 10, 2024 | Sale | $148.09 | 5,178 | 766,785 | 15,947 | Jun 11, 2024, 04:05 PM | |
MRNA | Moderna, Inc. | Shannon Thyme Klinger | Chief Legal Officer | Jun 07, 2024 | Option/RSU Exercise | - | 10,247 | - | 21,125 | Jun 11, 2024, 04:05 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Jun 05, 2024 | Sale | $151.25 | 15,000 | 2,268,804 | 1,961,031 | Jun 07, 2024, 07:00 PM | |
MRNA | Moderna, Inc. | James M. Mock | Chief Financial Officer | May 31, 2024 | Option/RSU Exercise | - | 1,326 | - | 7,197 | Jun 04, 2024, 05:27 PM | |
MRNA | Moderna, Inc. | James M. Mock | Chief Financial Officer | Jun 03, 2024 | Sale | $140.72 | 691 | 97,237 | 6,506 | Jun 04, 2024, 05:27 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | May 31, 2024 | Option/RSU Exercise | - | 651 | - | 1,472,428 | Jun 04, 2024, 05:20 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | Jun 03, 2024 | Sale | $140.72 | 339 | 47,704 | 1,472,089 | Jun 04, 2024, 05:20 PM | |
MRNA | Moderna, Inc. | Shannon Thyme Klinger | Chief Legal Officer | May 31, 2024 | Option/RSU Exercise | - | 232 | - | 11,000 | Jun 04, 2024, 05:12 PM | |
MRNA | Moderna, Inc. | Shannon Thyme Klinger | Chief Legal Officer | Jun 03, 2024 | Sale | $140.72 | 122 | 17,168 | 10,878 | Jun 04, 2024, 05:12 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | May 29, 2024 | Sale | $145.08 | 20,000 | 2,901,585 | 1,980,931 | May 31, 2024, 07:00 PM | |
MRNA | Moderna, Inc. | James M. Mock | Chief Financial Officer | May 28, 2024 | Option/RSU Exercise | - | 328 | - | 6,054 | May 30, 2024, 04:36 PM | |
MRNA | Moderna, Inc. | James M. Mock | Chief Financial Officer | May 29, 2024 | Sale | $144.50 | 183 | 26,444 | 5,871 | May 30, 2024, 04:36 PM | |
MRNA | Moderna, Inc. | Shannon Thyme Klinger | Chief Legal Officer | May 28, 2024 | Option/RSU Exercise | - | 328 | - | 10,951 | May 30, 2024, 04:27 PM | |
MRNA | Moderna, Inc. | Shannon Thyme Klinger | Chief Legal Officer | May 29, 2024 | Sale | $144.50 | 183 | 26,444 | 10,768 | May 30, 2024, 04:27 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | May 28, 2024 | Option/RSU Exercise | - | 610 | - | 1,472,118 | May 30, 2024, 04:14 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | May 29, 2024 | Sale | $144.50 | 341 | 49,276 | 1,471,777 | May 30, 2024, 04:14 PM | |
MRNA | Moderna, Inc. | James M. Mock | Chief Financial Officer | May 28, 2024 | Sale | $162.47 | 648 | 105,283 | 5,726 | May 29, 2024, 04:16 PM | |
MRNA | Moderna, Inc. | James M. Mock | Chief Financial Officer | May 24, 2024 | Option/RSU Exercise | - | 1,326 | - | 6,374 | May 29, 2024, 04:16 PM | |
MRNA | Moderna, Inc. | Shannon Thyme Klinger | Chief Legal Officer | May 24, 2024 | Option/RSU Exercise | - | 2,652 | - | 11,919 | May 29, 2024, 04:12 PM | |
MRNA | Moderna, Inc. | Shannon Thyme Klinger | Chief Legal Officer | May 28, 2024 | Sale | $162.47 | 1,296 | 210,566 | 10,623 | May 29, 2024, 04:12 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | May 22, 2024 | Sale | $157.57 | 15,000 | 2,363,556 | 1,996,831 | May 24, 2024, 07:00 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | May 15, 2024 | Sale | $127.32 | 15,000 | 1,909,863 | 2,007,443 | May 17, 2024, 07:00 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | May 15, 2024 | Sale | $127.49 | 15,000 | 1,912,350 | 1,471,508 | May 17, 2024, 04:04 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | May 09, 2024 | Option/RSU Exercise | - | 522 | - | 1,486,763 | May 13, 2024, 04:03 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | May 10, 2024 | Sale | $120.96 | 255 | 30,844 | 1,486,508 | May 13, 2024, 04:03 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | May 08, 2024 | Sale | $121.68 | 15,000 | 1,825,220 | 2,024,931 | May 10, 2024, 07:00 PM | |
MRNA | Moderna, Inc. | Stephen Berenson | Director | May 03, 2024 | Option/RSU Exercise | - | 732 | - | 22,203 | May 07, 2024, 05:10 PM | |
MRNA | Moderna, Inc. | Elizabeth G. Nabel | Director | May 03, 2024 | Option/RSU Exercise | - | 732 | - | 2,105 | May 07, 2024, 04:48 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | May 01, 2024 | Sale | $110.92 | 15,000 | 1,663,855 | 2,037,949 | May 03, 2024, 07:00 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Apr 24, 2024 | Sale | $108.32 | 15,000 | 1,624,836 | 2,053,005 | Apr 26, 2024, 07:00 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Apr 17, 2024 | Sale | $103.38 | 15,000 | 1,550,703 | 2,063,688 | Apr 19, 2024, 07:00 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | Apr 15, 2024 | Sale | $105.02 | 15,000 | 1,575,300 | 1,486,241 | Apr 16, 2024, 04:23 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Apr 10, 2024 | Sale | $107.12 | 15,000 | 1,606,865 | 2,080,580 | Apr 12, 2024, 07:00 PM | |
MRNA | Moderna, Inc. | James M. Mock | Chief Financial Officer | Apr 05, 2024 | Option/RSU Exercise | - | 1,453 | - | 5,753 | Apr 09, 2024, 04:09 PM | |
MRNA | Moderna, Inc. | James M. Mock | Chief Financial Officer | Apr 08, 2024 | Sale | $101.93 | 705 | 71,859 | 5,048 | Apr 09, 2024, 04:09 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Apr 03, 2024 | Sale | $101.68 | 15,000 | 1,525,268 | 2,101,731 | Apr 05, 2024, 07:00 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Mar 27, 2024 | Sale | $109.06 | 15,000 | 1,635,864 | 2,115,114 | Mar 29, 2024, 07:00 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Mar 20, 2024 | Sale | $102.39 | 15,000 | 1,535,820 | 2,129,818 | Mar 22, 2024, 07:00 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | Mar 15, 2024 | Sale | $103.17 | 15,000 | 1,547,550 | 1,501,241 | Mar 19, 2024, 04:39 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Mar 13, 2024 | Sale | $108.54 | 15,000 | 1,628,031 | 2,140,650 | Mar 15, 2024, 07:00 PM | |
MRNA | Moderna, Inc. | Shannon Thyme Klinger | Chief Legal Officer | Mar 07, 2024 | Option/RSU Exercise | - | 1,138 | - | 9,811 | Mar 11, 2024, 09:05 AM | |
MRNA | Moderna, Inc. | Shannon Thyme Klinger | Chief Legal Officer | Mar 08, 2024 | Sale | $99.05 | 544 | 53,884 | 9,267 | Mar 11, 2024, 09:05 AM | |
MRNA | Moderna, Inc. | Shannon Thyme Klinger | Chief Legal Officer | Mar 04, 2024 | Sale | $94.34 | 117 | 11,038 | 8,673 | Mar 05, 2024, 05:56 PM | |
MRNA | Moderna, Inc. | Shannon Thyme Klinger | Chief Legal Officer | Mar 01, 2024 | Option/RSU Exercise | - | 233 | - | 8,790 | Mar 05, 2024, 05:56 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | Mar 01, 2024 | Option/RSU Exercise | - | 652 | - | 1,516,550 | Mar 05, 2024, 05:52 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | Mar 04, 2024 | Sale | $94.34 | 309 | 29,151 | 1,516,241 | Mar 05, 2024, 05:52 PM | |
MRNA | Moderna, Inc. | James M. Mock | Chief Financial Officer | Feb 28, 2024 | Option/RSU Exercise | - | 1,315 | - | 4,947 | Mar 01, 2024, 05:33 PM | |
MRNA | Moderna, Inc. | James M. Mock | Chief Financial Officer | Feb 29, 2024 | Sale | $94.57 | 647 | 61,188 | 4,300 | Mar 01, 2024, 05:33 PM | |
MRNA | Moderna, Inc. | Shannon Thyme Klinger | Chief Legal Officer | Feb 29, 2024 | Sale | $94.57 | 670 | 63,363 | 8,557 | Mar 01, 2024, 05:29 PM | |
MRNA | Moderna, Inc. | Shannon Thyme Klinger | Chief Legal Officer | Feb 28, 2024 | Option/RSU Exercise | - | 1,315 | - | 9,227 | Mar 01, 2024, 05:29 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | Feb 28, 2024 | Option/RSU Exercise | - | 4,853 | - | 1,518,286 | Mar 01, 2024, 05:25 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | Feb 29, 2024 | Sale | $94.57 | 2,388 | 225,838 | 1,515,898 | Mar 01, 2024, 05:25 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | Feb 22, 2024 | Sale | $100.00 | 15,000 | 1,500,000 | 1,513,433 | Feb 23, 2024, 04:04 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | Feb 16, 2024 | Sale | $88.88 | 10,542 | 936,981 | 1,528,433 | Feb 16, 2024, 04:19 PM | |
MRNA | Moderna, Inc. | Stephane Bancel | Chief Executive Officer | Feb 16, 2024 | Sale | $88.88 | 26,351 | 2,342,098 | 5,460,224 | Feb 16, 2024, 04:10 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | Feb 09, 2024 | Option/RSU Exercise | - | 522 | - | 1,516,585 | Feb 13, 2024, 04:13 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | Feb 12, 2024 | Sale | $86.23 | 304 | 26,214 | 1,516,281 | Feb 13, 2024, 04:13 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | Jan 16, 2024 | Sale | $103.90 | 15,000 | 1,558,500 | 1,516,063 | Jan 17, 2024, 04:12 PM | |
MRNA | Moderna, Inc. | James M. Mock | Chief Financial Officer | Jan 08, 2024 | Sale | $109.75 | 772 | 84,731 | 3,632 | Jan 09, 2024, 04:08 PM | |
MRNA | Moderna, Inc. | James M. Mock | Chief Financial Officer | Jan 05, 2024 | Option/RSU Exercise | - | 1,452 | - | 4,404 | Jan 09, 2024, 04:08 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | Dec 27, 2023 | Sale | $100.01 | 45,000 | 4,500,450 | 1,531,063 | Dec 28, 2023, 08:00 AM | |
MRNA | Moderna, Inc. | Shannon Thyme Klinger | Chief Legal Officer | Dec 07, 2023 | Option/RSU Exercise | - | 1,139 | - | 8,475 | Dec 11, 2023, 04:03 PM | |
MRNA | Moderna, Inc. | Shannon Thyme Klinger | Chief Legal Officer | Dec 08, 2023 | Sale | $79.09 | 563 | 44,525 | 7,912 | Dec 11, 2023, 04:03 PM | |
MRNA | Moderna, Inc. | Arpa Garay | Chief Commercial Officer | Dec 06, 2023 | Sale | $78.34 | 564 | 44,182 | 3,690 | Dec 07, 2023, 04:21 PM | |
MRNA | Moderna, Inc. | Arpa Garay | Chief Commercial Officer | Dec 05, 2023 | Option/RSU Exercise | - | 1,141 | - | 4,254 | Dec 07, 2023, 04:21 PM | |
MRNA | Moderna, Inc. | Shannon Thyme Klinger | Chief Legal Officer | Dec 01, 2023 | Option/RSU Exercise | - | 232 | - | 7,447 | Dec 05, 2023, 04:10 PM | |
MRNA | Moderna, Inc. | Shannon Thyme Klinger | Chief Legal Officer | Dec 04, 2023 | Sale | $79.31 | 111 | 8,804 | 7,336 | Dec 05, 2023, 04:10 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | Dec 01, 2023 | Option/RSU Exercise | - | 651 | - | 1,576,372 | Dec 05, 2023, 04:07 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | Dec 04, 2023 | Sale | $79.31 | 309 | 24,508 | 1,576,063 | Dec 05, 2023, 04:07 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | Nov 28, 2023 | Option/RSU Exercise | - | 2,411 | - | 1,576,857 | Nov 30, 2023, 04:11 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | Nov 29, 2023 | Sale | $79.81 | 1,136 | 90,666 | 1,575,721 | Nov 30, 2023, 04:11 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | Nov 09, 2023 | Option/RSU Exercise | - | 522 | - | 1,574,709 | Nov 13, 2023, 04:02 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | Nov 10, 2023 | Sale | $68.76 | 263 | 18,084 | 1,574,446 | Nov 13, 2023, 04:02 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Nov 01, 2023 | Sale | $76.00 | 10,000 | 760,032 | 2,155,031 | Nov 03, 2023, 07:00 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Oct 25, 2023 | Sale | $76.99 | 10,000 | 769,854 | 2,160,431 | Oct 27, 2023, 07:00 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Oct 11, 2023 | Sale | $103.30 | 15,000 | 1,549,441 | 2,173,231 | Oct 13, 2023, 07:00 PM | |
MRNA | Moderna, Inc. | James M. Mock | Chief Financial Officer | Oct 05, 2023 | Option/RSU Exercise | - | 5,810 | - | 5,810 | Oct 10, 2023, 04:51 PM | |
MRNA | Moderna, Inc. | James M. Mock | Chief Financial Officer | Oct 06, 2023 | Sale | $102.50 | 2,858 | 292,953 | 2,952 | Oct 10, 2023, 04:51 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Oct 04, 2023 | Sale | $102.72 | 15,000 | 1,540,845 | 2,195,901 | Oct 06, 2023, 07:02 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Sep 27, 2023 | Sale | $98.96 | 10,000 | 989,646 | 2,201,727 | Sep 29, 2023, 07:00 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Sep 20, 2023 | Sale | $104.74 | 15,000 | 1,571,090 | 2,217,317 | Sep 22, 2023, 07:00 PM | |
MRNA | Moderna, Inc. | Stephen Hoge | President | Sep 15, 2023 | Sale | $112.99 | 15,000 | 1,694,850 | 1,574,187 | Sep 18, 2023, 04:06 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Sep 13, 2023 | Sale | $109.70 | 15,000 | 1,645,522 | 2,232,650 | Sep 15, 2023, 07:00 PM | |
MRNA | Moderna, Inc. | Shannon Thyme Klinger | Chief Legal Officer | Sep 07, 2023 | Option/RSU Exercise | - | 1,138 | - | 7,772 | Sep 11, 2023, 04:02 PM | |
MRNA | Moderna, Inc. | Shannon Thyme Klinger | Chief Legal Officer | Sep 08, 2023 | Sale | $107.22 | 557 | 59,722 | 7,215 | Sep 11, 2023, 04:02 PM | |
MRNA | Moderna, Inc. | Noubar Afeyan | Director | Sep 06, 2023 | Sale | $107.61 | 15,000 | 1,614,093 | 1,988,198 | Sep 08, 2023, 07:01 PM |